AAAAAA

   
Results: 1-24 |
Results: 24
ACTIVATED PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM PATIENTS RECEIVING SUBCUTANEOUS INTERLEUKIN-2 FOLLOWING AUTOLOGOUS STEM-CELL TRANSPLANTATION PROLONG SURVIVAL OF SCID MICE BEARING HUMAN LYMPHOMA
Authors: KATSANIS E WEISDORF DJ MILLER JS
Citation: E. Katsanis et al., ACTIVATED PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM PATIENTS RECEIVING SUBCUTANEOUS INTERLEUKIN-2 FOLLOWING AUTOLOGOUS STEM-CELL TRANSPLANTATION PROLONG SURVIVAL OF SCID MICE BEARING HUMAN LYMPHOMA, Bone marrow transplantation, 22(2), 1998, pp. 185-191
IMPROVED IMMUNOSTIMULATORY FUNCTION OF BONE-MARROW-DERIVED MACROPHAGES TRANSDUCED WITH THE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTORGENE
Authors: XU ZY KATSANIS E
Citation: Zy. Xu et E. Katsanis, IMPROVED IMMUNOSTIMULATORY FUNCTION OF BONE-MARROW-DERIVED MACROPHAGES TRANSDUCED WITH THE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTORGENE, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 12(1), 1997, pp. 27-36
PATTERNS OF HEPATIC AND SPLENIC COLONIZATION BY AN ATTENUATED STRAIN OF SALMONELLA-TYPHIMURIUM CONTAINING THE GENE FOR HUMAN INTERLEUKIN-2 - A NOVEL ANTITUMOR AGENT
Authors: SALTZMAN DA KATSANIS E HEISE CP HASZ DE KELLY SM CURTISS R LEONARD AS ANDERSON PM
Citation: Da. Saltzman et al., PATTERNS OF HEPATIC AND SPLENIC COLONIZATION BY AN ATTENUATED STRAIN OF SALMONELLA-TYPHIMURIUM CONTAINING THE GENE FOR HUMAN INTERLEUKIN-2 - A NOVEL ANTITUMOR AGENT, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 12(1), 1997, pp. 37-45
UNRELATED DONOR BONE-MARROW TRANSPLANTATION FOR CHILDREN WITH ACUTE-LEUKEMIA
Authors: DAVIES SM WAGNER JE SHU XO BLAZAR BR KATSANIS E ORCHARD PJ KERSEY JH DUSENBERY KE WEISDORF DJ MCGLAVE PB RAMSAY NKC
Citation: Sm. Davies et al., UNRELATED DONOR BONE-MARROW TRANSPLANTATION FOR CHILDREN WITH ACUTE-LEUKEMIA, Journal of clinical oncology, 15(2), 1997, pp. 557-565
NEBULIZED INTERLEUKIN-2 LIPOSOMES - AEROSOL CHARACTERISTICS AND BIODISTRIBUTION
Authors: KHANNA C WALDREP JC ANDERSON PM WEISCHELBAUM RW HASZ DE KATSANIS E KLAUSNER JS
Citation: C. Khanna et al., NEBULIZED INTERLEUKIN-2 LIPOSOMES - AEROSOL CHARACTERISTICS AND BIODISTRIBUTION, Journal of Pharmacy and Pharmacology, 49(10), 1997, pp. 960-971
ANTITUMOR MECHANISMS OF ATTENUATED SALMONELLA-TYPHIMURIUM CONTAINING THE GENE FOR HUMAN INTERLEUKIN-2 - A NOVEL ANTITUMOR AGENT
Authors: SALTZMAN DA KATSANIS E HEISE CP HASZ DE VIGDOROVICH V KELLY SM CURTISS R LEONARD AS ANDERSON PM
Citation: Da. Saltzman et al., ANTITUMOR MECHANISMS OF ATTENUATED SALMONELLA-TYPHIMURIUM CONTAINING THE GENE FOR HUMAN INTERLEUKIN-2 - A NOVEL ANTITUMOR AGENT, Journal of pediatric surgery, 32(2), 1997, pp. 301-306
INTERLEUKIN-2 LIPOSOME INHALATION-THERAPY IS SAFE AND EFFECTIVE FOR DOGS WITH SPONTANEOUS PULMONARY METASTASES
Authors: KHANNA C ANDERSON PM HASZ DE KATSANIS E NEVILLE M KLAUSNER JS
Citation: C. Khanna et al., INTERLEUKIN-2 LIPOSOME INHALATION-THERAPY IS SAFE AND EFFECTIVE FOR DOGS WITH SPONTANEOUS PULMONARY METASTASES, Cancer, 79(7), 1997, pp. 1409-1421
UNRELATED DONOR BONE-MARROW TRANSPLANTATION FOR CHILDREN AND ADOLESCENTS WITH APLASTIC-ANEMIA OR MYELODYSPLASIA
Authors: DAVIES SM WAGNER JE DEFOR T BLAZAR BR KATSANIS E KERSEY JH ORCHARD PJ MCGLAVE PB WEISDORF DJ RAMSAY NKC
Citation: Sm. Davies et al., UNRELATED DONOR BONE-MARROW TRANSPLANTATION FOR CHILDREN AND ADOLESCENTS WITH APLASTIC-ANEMIA OR MYELODYSPLASIA, British Journal of Haematology, 96(4), 1997, pp. 749-756
THE ROLE OF B7 COSTIMULATION BY MURINE ACUTE MYELOID-LEUKEMIA IN THE GENERATION AND FUNCTION OF A CD8(-CELL LINE WITH POTENT IN-VIVO GRAFT-VERSUS-LEUKEMIA PROPERTIES() T)
Authors: BOYER MW VALLERA DA TAYLOR PA GRAY GS KATSANIS E GORDEN K ORCHARD PJ BLAZAR BR
Citation: Mw. Boyer et al., THE ROLE OF B7 COSTIMULATION BY MURINE ACUTE MYELOID-LEUKEMIA IN THE GENERATION AND FUNCTION OF A CD8(-CELL LINE WITH POTENT IN-VIVO GRAFT-VERSUS-LEUKEMIA PROPERTIES() T), Blood, 89(9), 1997, pp. 3477-3485
INTERLEUKIN-2 SECRETION BY TRANSDUCED AND UNSELECTED BDL-2 LYMPHOMA RESULTS IN INCREASED SURVIVAL IN MICE WITH PREVIOUSLY ESTABLISHED DISSEMINATED DISEASE
Authors: ORCHARD PJ KATSANIS E BOYER M MAY C MCIVOR RS BLAZAR BR
Citation: Pj. Orchard et al., INTERLEUKIN-2 SECRETION BY TRANSDUCED AND UNSELECTED BDL-2 LYMPHOMA RESULTS IN INCREASED SURVIVAL IN MICE WITH PREVIOUSLY ESTABLISHED DISSEMINATED DISEASE, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 11(2), 1996, pp. 155-164
EFFECTIVE IMMUNIZATION AGAINST NEUROBLASTOMA USING DOUBLE-TRANSDUCED TUMOR-CELLS SECRETING GM-CSF INTERFERON-GAMMA
Authors: BAUSERO MA PANOSKALTSISMORTARI A BLAZAR BR KATSANIS E
Citation: Ma. Bausero et al., EFFECTIVE IMMUNIZATION AGAINST NEUROBLASTOMA USING DOUBLE-TRANSDUCED TUMOR-CELLS SECRETING GM-CSF INTERFERON-GAMMA, Journal of immunotherapy with emphasis on tumor immunology, 19(2), 1996, pp. 113-124
IRRADIATION OF SINGLY AND DOUBLY TRANSDUCED MURINE NEUROBLASTOMA-CELLS EXPRESSING B7-1 AND PRODUCING INTERFERON-GAMMA REDUCES THEIR CAPACITY TO INDUCE SYSTEMIC IMMUNITY
Authors: KATSANIS E BAUSERO MA PANOSKALTSISMORTARI A DANCISAK BB XU ZY ORCHARD PJ DAVIS CG BLAZAR BR
Citation: E. Katsanis et al., IRRADIATION OF SINGLY AND DOUBLY TRANSDUCED MURINE NEUROBLASTOMA-CELLS EXPRESSING B7-1 AND PRODUCING INTERFERON-GAMMA REDUCES THEIR CAPACITY TO INDUCE SYSTEMIC IMMUNITY, Cancer gene therapy, 3(2), 1996, pp. 75-82
LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 AFTER AUTOLOGOUS BMT SAFELY AUGMENTS NK ACTIVITY
Authors: MILLER JS TUCK J WEISDORF D MCGLAVE P BLAZAR B KATSANIS E VERFAILLE C LEBKOWKSI J RADFORD J BURNS L
Citation: Js. Miller et al., LOW-DOSE SUBCUTANEOUS INTERLEUKIN-2 AFTER AUTOLOGOUS BMT SAFELY AUGMENTS NK ACTIVITY, Experimental hematology, 24(9), 1996, pp. 349-349
IL-15 ADMINISTRATION FOLLOWING SYNGENEIC BONE-MARROW TRANSPLANTATION PROLONGS SURVIVAL OF LYMPHOMA BEARING MICE
Authors: KATSANIS E XU ZY PANOSKALTSISMORTARI A WEISDORF DJ WIDMER MB BLAZAR BR
Citation: E. Katsanis et al., IL-15 ADMINISTRATION FOLLOWING SYNGENEIC BONE-MARROW TRANSPLANTATION PROLONGS SURVIVAL OF LYMPHOMA BEARING MICE, Transplantation, 62(6), 1996, pp. 872-875
UNRELATED DONOR BONE-MARROW TRANSPLANTATION FOR CHILDREN AND ADOLESCENTS WITH APLASTIC-ANEMIA OR MYELODYSPLASIA
Authors: DAVIES SM WAGNER JE DEFOR T BLAZAR BR KATSANIS E KERSEY JH ORCHARD PJ MCGLAVE PB WEISDORF DJ RAMSAY NKC
Citation: Sm. Davies et al., UNRELATED DONOR BONE-MARROW TRANSPLANTATION FOR CHILDREN AND ADOLESCENTS WITH APLASTIC-ANEMIA OR MYELODYSPLASIA, Blood, 88(10), 1996, pp. 1056-1056
SUBCUTANEOUS IL-2 AFTER AUTOLOGOUS BMT EXPANDS NK IN-VIVO BUT REQUIRES EX-VIVO HIGH-DOSE IL-2 FOR MAXIMAL ACTIVATION
Authors: MILLER JS TESSMERTUCK J PIERSON BA WEISDORF D MCGLAVE P BLAZAR B KATSANIS E VERFAILLE C BURNS L
Citation: Js. Miller et al., SUBCUTANEOUS IL-2 AFTER AUTOLOGOUS BMT EXPANDS NK IN-VIVO BUT REQUIRES EX-VIVO HIGH-DOSE IL-2 FOR MAXIMAL ACTIVATION, Blood, 88(10), 1996, pp. 2426-2426
B7-1 EXPRESSION DECREASES TUMORIGENICITY AND INDUCES PARTIAL SYSTEMICIMMUNITY TO MURINE NEUROBLASTOMA DEFICIENT IN MAJOR HISTOCOMPATIBILITY COMPLEX AND COSTIMULATORY MOLECULES
Authors: KATSANIS E XU ZY BAUSERO MA DANCISAK BB GORDEN KB DAVIS G GRAY GS ORCHARD PJ BLAZAR BR
Citation: E. Katsanis et al., B7-1 EXPRESSION DECREASES TUMORIGENICITY AND INDUCES PARTIAL SYSTEMICIMMUNITY TO MURINE NEUROBLASTOMA DEFICIENT IN MAJOR HISTOCOMPATIBILITY COMPLEX AND COSTIMULATORY MOLECULES, Cancer gene therapy, 2(1), 1995, pp. 39-46
IL-15 ADMINISTRATION FOLLOWING SYNGENEIC MURINE BONE-MARROW TRANSPLANTATION (BMT) FOR LYMPHOMA IMPROVES SURVIVAL AND HAS DECREASED TOXICITYWHEN COMPARED TO IL-2
Authors: KATSANIS E XU Z PANOSKALTSISMORTARI A HASZ DE WEISDORF DJ WIDMER MB BLAZAR BR
Citation: E. Katsanis et al., IL-15 ADMINISTRATION FOLLOWING SYNGENEIC MURINE BONE-MARROW TRANSPLANTATION (BMT) FOR LYMPHOMA IMPROVES SURVIVAL AND HAS DECREASED TOXICITYWHEN COMPARED TO IL-2, Blood, 86(10), 1995, pp. 2272-2272
INTERLEUKIN-2 GENE-TRANSFER INTO MURINE NEUROBLASTOMA DECREASES TUMORIGENICITY AND ENHANCES SYSTEMIC IMMUNITY CAUSING REGRESSION OF PREESTABLISHED RETROPERITONEAL TUMORS
Authors: KATSANIS E ORCHARD PJ BAUSERO MA GORDEN KB MCIVOR RS BLAZAR BR
Citation: E. Katsanis et al., INTERLEUKIN-2 GENE-TRANSFER INTO MURINE NEUROBLASTOMA DECREASES TUMORIGENICITY AND ENHANCES SYSTEMIC IMMUNITY CAUSING REGRESSION OF PREESTABLISHED RETROPERITONEAL TUMORS, Journal of immunotherapy with emphasis on tumor immunology, 15(2), 1994, pp. 81-90
TRANSFECTION OF THE MOUSE ICAM-1 GENE INTO MURINE NEUROBLASTOMA ENHANCES SUSCEPTIBILITY TO LYSIS, REDUCES IN-VIVO TUMORIGENICITY AND DECREASES ICAM-2-DEPENDENT KILLING
Authors: KATSANIS E BAUSERO MA XU H ORCHARD PJ XU ZY MCIVOR RS BRIAN AA BLAZAR BR
Citation: E. Katsanis et al., TRANSFECTION OF THE MOUSE ICAM-1 GENE INTO MURINE NEUROBLASTOMA ENHANCES SUSCEPTIBILITY TO LYSIS, REDUCES IN-VIVO TUMORIGENICITY AND DECREASES ICAM-2-DEPENDENT KILLING, Cancer immunology and immunotherapy, 38(2), 1994, pp. 135-141
INFUSIONS OF INTERLEUKIN-1-ALPHA AFTER AUTOLOGOUS TRANSPLANTATION FORHODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA INDUCE EFFECTOR-CELLS WITHANTI-LYMPHOMA CYTOLYTIC ACTIVITY
Authors: KATSANIS E WEISDORF DJ XU ZY DANCISAK BB HALET ML BLAZAR BR
Citation: E. Katsanis et al., INFUSIONS OF INTERLEUKIN-1-ALPHA AFTER AUTOLOGOUS TRANSPLANTATION FORHODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA INDUCE EFFECTOR-CELLS WITHANTI-LYMPHOMA CYTOLYTIC ACTIVITY, Journal of clinical immunology, 14(3), 1994, pp. 205-211
SHORT-TERM EX-VIVO ACTIVATION OF SPLENOCYTES WITH ANTI-CD3 PLUS IL-2 AND INFUSION POST-BMT INTO MICE RESULTS IN IN-VIVO EXPANSION OF EFFECTOR-CELLS WITH POTENT ANTI-LYMPHOMA ACTIVITY
Authors: KATSANIS E XU Z ANDERSON PM DANCISAK BB BAUSERO MA WEISDORF DJ BLAZAR BR OCHOA AC
Citation: E. Katsanis et al., SHORT-TERM EX-VIVO ACTIVATION OF SPLENOCYTES WITH ANTI-CD3 PLUS IL-2 AND INFUSION POST-BMT INTO MICE RESULTS IN IN-VIVO EXPANSION OF EFFECTOR-CELLS WITH POTENT ANTI-LYMPHOMA ACTIVITY, Bone marrow transplantation, 14(4), 1994, pp. 563-572
RETROPERITONEAL INOCULATION OF MURINE NEUROBLASTOMA RESULTS IN A RELIABLE MODEL FOR EVALUATION OF THE ANTITUMOR IMMUNE-RESPONSE
Authors: KATSANIS E BLAZAR BR BAUSERO MA GUNTHER R ANDERSON PM
Citation: E. Katsanis et al., RETROPERITONEAL INOCULATION OF MURINE NEUROBLASTOMA RESULTS IN A RELIABLE MODEL FOR EVALUATION OF THE ANTITUMOR IMMUNE-RESPONSE, Journal of pediatric surgery, 29(4), 1994, pp. 538-542
INTERLEUKIN-1-ALPHA ADMINISTERED AFTER AUTOLOGOUS TRANSPLANTATION - APHASE I II CLINICAL-TRIAL/
Authors: WEISDORF D KATSANIS E VERFAILLIE C RAMSAY NKC HAAKE R GARRISON L BLAZAR BR
Citation: D. Weisdorf et al., INTERLEUKIN-1-ALPHA ADMINISTERED AFTER AUTOLOGOUS TRANSPLANTATION - APHASE I II CLINICAL-TRIAL/, Blood, 84(6), 1994, pp. 2044-2049
Risultati: 1-24 |